This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education.
Supported by an educational grant from Sanofi Genzyme.
Target Audience: Neurologists, nursing professionals, pharmacists, PAs, rehabilitation specialists, mental health professionals, and other healthcare professionals who manage people with MS within a team-based practice environment.
All other health care professionals completing this course will be issued a statement of participation.
This series consists of 3 continuing education activities, the links below will be live and take you to activity details and content.
Module 1 – 1,800 Seconds in the Role of Oral Therapies in MS Treatment
Module 2 – 1,800 Seconds in the Role of Monoclonal Antibodies in MS Treatment
Module 3 – 1,800 Seconds in Strategies for Switching Therapies in MS